Skip to main content
. 2021 Jan 26;36(6):1605–1612. doi: 10.1007/s11606-021-06590-2

Table 3.

Percentage of Respondents in Medicaid Expansion and Non-Expansion States Who Received an HIV Test in the Last Year, Before and After 2014 Expansion

Percentage with HIV testing the last year (%) [95% CI]a
Non-expansion states Expansion states
Pre-Exp. Post-Exp. Δb Pre-Exp. Post-Exp. Δb DiDc DDDd
All 18 [17, 18] 17 [16, 18] − 0.7 18 [17, 19] 18 [17, 18] − 0.3 0.4 N/A
PCP 19 [18, 20] 18 [17, 19] − 0.8 19 [19, 20] 19 [18, 19] − 0.7 0.1 N/A
No PCP 16 [15, 17] 15 [14, 17] − 0.5 16 [15, 17] 16 [14, 17] 0.1 0.6 N/A
Race
  Non-Hisp. White 12 [12, 13] 12 [11, 13] − 0.1 12 [12, 13] 13 [36, 37] 0.5 0.6 Ref
  Non-Hisp. Black 33 [31, 35] 31 [29, 33] − 1.5 38 [36, 40] 37 [59, 63] − 1.3 0.2 − 0.4
  Hispanic 16 [14, 17] 15 [14, 17] − 0.1 19 [18, 20] 18 [42, 44] − 1.0 − 0.9 − 1.5
  Other 18 [15, 20] 15 [12, 17] − 3.1 13 [12, 15] 15 [35, 40] 1.5 4.6 4.0
Race-sex
  White male 11 [10, 13] 11 [10, 13] 0.1 12 [11, 13] 12 [11, 13] 0.1 0.1 Ref
  White female 13 [12, 14] 13 [38, 40] − 0.2 13 [12, 14] 13 [12, 14] 0.8 1.0 0.9
  Black male 30 [27, 33] 26 [23, 30] − 3.5 40 [38, 43] 36 [33, 39] − 4.0 − 0.4 − 0.5
  Black female 35 [33, 37] 34 [32, 37] − 0.3 63 [61, 65] 59 [57, 61] − 4.0 − 3.7 − 3.8
  Hispanic male 12 [10, 14] 10 [8, 12] − 1.8 15 [14, 17] 15 [13, 17] − 0.2 1.6 1.5
  Hispanic female 19 [17, 21] 20 [18, 22] 0.9 22 [21, 24] 20 [19, 22] − 2.1 − 3.0 − 3.1
  Other male 15 [11, 19] 12 [9, 15] − 3.5 12 [10, 15] 13 [10, 15] 0.5 4.0 3.9
  Other female 20 [17, 23] 18 [13, 22] − 2.2 14 [12, 17] 17 [14, 20] 2.2 4.4 4.4

aRegression-adjusted and survey-weighted predicted proportions. Covariates were age, sex, marital status, highest level of educational attainment, employment status, and whether the respondent was in the BRFSS cell phone sample. bAll absolute testing rates are rounded to the nearest percentage point; deltas are rounded to the nearest tenth percentage point. cDifference-in-differences compared within race or race-sex subgroup. dTriple difference-in-differences compared to reference group. *Significant at p < 0.05; **significant at p < 0.01